(VIANEWS) – The NASDAQ ended the session with Castle Biosciences (CSTL) jumping 4.76% to $35.20 on Tuesday while NASDAQ dropped 0.15% to $13,747.94.
Today’s last reported volume for Castle Biosciences is 261659, 7.67% above its average volume of 243019.
Castle Biosciences’s last close was $35.44, 67.09% below its 52-week high of $107.69.
Castle Biosciences’s Sales
Castle Biosciences’s sales growth is 53.2% for the present quarter and 39.2% for the next. The company’s growth estimates for the ongoing quarter and the next is a negative 73.9% and a negative 69.6%, respectively.
Castle Biosciences’s Revenue
Year-on-year quarterly revenue growth grew by 31%, now sitting on 68.04M for the twelve trailing months.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,
Castle Biosciences’s stock is considered to be oversold (<=20).
Castle Biosciences’s Stock Yearly Top and Bottom Value
Castle Biosciences’s stock is valued at $35.20 at 16:19 EST, way below its 52-week low of $39.34.
Castle Biosciences’s Moving Average
Castle Biosciences’s value is way under its 50-day moving average of $54.83 and way below its 200-day moving average of $64.52.
More news about Castle Biosciences (CSTL).